Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Oldenburg

Showing results (61-70 of 97) with videos related to

Pageof 10
Sort By:
Scandinavian Journal of Urology|November 23, 2022
Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019Eemil Karttunen, Petteri Hervonen, Abolfazl Hosseini Aliabad, et al.
Acta Oncologica (Stockholm, Sweden)|May 19, 2018
Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivorsLine V Hjelle, Per O M Gundersen, Ragnhild Hellesnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancerMette Sprauten, Thomas H Darrah, Derick R Peterson, et al.
European Urology Oncology|June 16, 2019
Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic ReviewStephen B Williams, Mohamed D Ray-Zack, Hogan K Hudgins, et al.
ESMO Open|July 17, 2020
Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinomaStefanie Aeppli, Eric Innocents Eboulet, Tim Eisen, et al.
The Oncologist|August 5, 2015
Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma--Analysis Using Diagnostic NodesChristian Rothermundt, Alexandra Bailey, Linda Cerbone, et al.
Trials|June 27, 2020
The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancerAlessio Crippa, Bram De Laere, Andrea Discacciati, et al.
European Urology|May 11, 2023
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer ConsortiumJohan Bjerner, Ola Bratt, Kirsti Aas, et al.
European Urology|March 16, 2021
Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021Christian Daniel Fankhauser, Jan Oldenburg, Peter Albers, et al.
European Urology|May 14, 2023
European Association of Urology Guidelines on Testicular Cancer: 2023 UpdateAnna Patrikidou, Walter Cazzaniga, Daniel Berney, et al.
Pageof 10

Showing results (61-70 of 97) with videos related to

Sort By:
Pageof 10
Scandinavian Journal of Urology|November 23, 2022
Incidence, mortality and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019Eemil Karttunen, Petteri Hervonen, Abolfazl Hosseini Aliabad, et al.
Acta Oncologica (Stockholm, Sweden)|May 19, 2018
Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivorsLine V Hjelle, Per O M Gundersen, Ragnhild Hellesnes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 21, 2011
Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancerMette Sprauten, Thomas H Darrah, Derick R Peterson, et al.
European Urology Oncology|June 16, 2019
Impact of Centralizing Care for Genitourinary Malignancies to High-volume Providers: A Systematic ReviewStephen B Williams, Mohamed D Ray-Zack, Hogan K Hudgins, et al.
ESMO Open|July 17, 2020
Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinomaStefanie Aeppli, Eric Innocents Eboulet, Tim Eisen, et al.
The Oncologist|August 5, 2015
Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma--Analysis Using Diagnostic NodesChristian Rothermundt, Alexandra Bailey, Linda Cerbone, et al.
Trials|June 27, 2020
The ProBio trial: molecular biomarkers for advancing personalized treatment decision in patients with metastatic castration-resistant prostate cancerAlessio Crippa, Bram De Laere, Andrea Discacciati, et al.
European Urology|May 11, 2023
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer ConsortiumJohan Bjerner, Ola Bratt, Kirsti Aas, et al.
European Urology|March 16, 2021
Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021Christian Daniel Fankhauser, Jan Oldenburg, Peter Albers, et al.
European Urology|May 14, 2023
European Association of Urology Guidelines on Testicular Cancer: 2023 UpdateAnna Patrikidou, Walter Cazzaniga, Daniel Berney, et al.
Pageof 10